Advertisement
US experts recommend second Johnson & Johnson Covid-19 shot
- Outside advisers to the FDA ask if the single-dose vaccine should actually be a two-dose one, citing low antibody levels compared to Pfizer and Moderna jabs
- US health officials are also looking into lowering the recommended age for Pfizer boosters
Reading Time:2 minutes
Why you can trust SCMP
Outside advisers to the US Food and Drug Administration on Friday unanimously recommended the agency authorise a second shot of Johnson & Johnson’s Covid-19 vaccine for all recipients of the one-dose inoculation.
Advertisement
The agency is also considering lowering the recommended age for booster shots of the Pfizer/BioNTech vaccine to people as young as 40, FDA official Dr Peter Marks told the advisory panel.
The FDA’s Vaccines and Related Biological Products Advisory Committee backed the shots for all J&J recipients aged 18 and older at least two months after their first dose.
The FDA is not bound to follow the recommendation, but typically does.
02:05
New laser injection technology could soon provide ‘pain-free’ vaccinations
New laser injection technology could soon provide ‘pain-free’ vaccinations
After hearing presentations from J&J and FDA scientists, many members of the advisory panel asked if J&J’s single-dose vaccine should actually be considered a two-dose shot for everyone.
Advertisement
Advertisement